Merck raised its sales and profit expectations for 2026.

Nov 4, 2026, 11:24 AM ETResultsRead the original at barchart.com

Good for MRK

Merck raised the bottom of its 2026 sales range and lifted its per-share profit range above the old range, including one-time deal and license costs. Its cost range also narrowed, but no earlier range is given for comparison.

MRK · Merck & Co., Inc.

AI read · Good for MRK

The AI's read

That means Merck expects more sales, and its new per-share profit range sits above its old range. The range includes one-time costs from the Cidara and Terns deals and the SciBrunch license, which makes the higher forecast more persuasive. The source gives no earlier cost range for comparison.

Get alerts for MRK

Follow Merck & Co., Inc. (MRK) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MRK

Free on the App Store and Google Play, or on the web.